Back to Search
JACKOLINE COSTANTINO, PHARM.D, BCCP
PHARM.D, BCCP
Cardiology Pharmacist
NPI: 1750754685Individual
Specialties, Licenses & Credentials
Cardiology PharmacistPrimary
Pharmacist — Cardiology
Code: 1835C0206X
P6864(ID)
Research & Publications (20)
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19252137·J Clin Oncol·2009
6-review
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
PMID 19349544·J Clin Oncol·2009
2-rct
The use of tamoxifen and raloxifene for the prevention of breast cancer.
PMID 19213563·Recent Results Cancer Res·2009
6-review
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
PMID 18302020·Breast Cancer Res Treat·2009
4-observational
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19249063·J Urol·2009
6-review
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.
PMID 18929150·Semin Oncol·2008
6-review
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.
PMID 18927301·Clin Cancer Res·2008
4-observational
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
PMID 18332472·J Clin Oncol·2008
4-observational
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer.
PMID 18840821·J Natl Cancer Inst·2008
3-trial
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
PMID 17851765·Breast Cancer Res Treat·2008
8-other
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
PMID 18650162·Clin Breast Cancer·2008
2-rct
Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.
PMID 17940979·J Infect Dis·2007
7-preclinical
Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.
PMID 17991930·J Clin Oncol·2007
6-review
Projecting individualized absolute invasive breast cancer risk in African American women.
PMID 18042936·J Natl Cancer Inst·2007
4-observational
Is sentinel node biopsy necessary in conservatively treated DCIS?
PMID 17534687·Ann Surg Oncol·2007
8-other
Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
PMID 17580274·Am J Clin Pathol·2007
8-other
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
PMID 17851130·Lancet Oncol·2007
3-trial
Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0): National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-21.
PMID 17896781·Cancer·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3551 ROGER BROOKE DR
JBSA FT SAM HOUSTON, TX 78234 - Phone
- (210) 916-0890
Quick Facts
- NPI
- 1750754685
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile